BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Les Turner ALS Foundation - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://lesturnerals.org
X-WR-CALDESC:Events for Les Turner ALS Foundation
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20240310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20241103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20250309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20251102T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20260308T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20261101T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20250331T120000
DTEND;TZID=America/Chicago:20250331T130000
DTSTAMP:20260524T210050
CREATED:20250310T200012Z
LAST-MODIFIED:20250310T200012Z
UID:10002217-1743422400-1743426000@lesturnerals.org
SUMMARY:March ALS Learning Series Webinar : Observational Studies Help in the Quest for Effective ALS Therapies
DESCRIPTION:Monday\, March 31\, at 12 CST\nAbout the Program: In this talk Dr. Berry will discuss the aims\, design considerations\, and implementation of observational studies\, highlighting the many ways observational studies hastened drug development and can create resources that aid the ALS community in the present and for years to come.    \nThe Les Turner ALS Foundation is proud to offer this webinar at no cost to the ALS community. Thank you to the Gilbert & Jacqueline Fern Foundation\, Biogen\, & Mitsubishi Tanabe Pharma America for sponsoring this webinar.  \nAbout the Speaker: James D. Berry\, MD\, MPH\nWinthrop Family Scholar in ALS Sciences  \nAverill Healey Endowed Chair in ALS  \nChief of the MGH Division of ALS and Motor Neuron Diseases  \n Dr. Berry leads the Massachusetts General Hospital Division of ALS and Motor Neuron Diseases. He is an active clinician and ALS clinical researcher\, with a focus on biomarker development and ALS clinical trial methodology. He oversees a large biorepository\, collecting\, storing and sharing blood\, DNA\, and spinal fluid and accompanying patient information\, which allows researchers around the globe to conduct critical research identifying biomarkers of ALS and developing novel therapeutics. He also leads projects developing digital endpoints for ALS trials that will help increase the objective data for trials while decreasing the burden on trial participants. Finally\, he is deeply committed to developing novel therapeutics by translating discoveries in the lab into clinical trials and leading clinical trials that will transform our approach to care in ALS.    \nDr. Berry also oversees and leads out the clinic at the Healey Center for ALS\, caring for patients and helping to build and lead the multidisciplinary care team. He helped found the Telemedicine for People with ALS (TelePALS) program\, the ALS House Call Program and the Parenting at a Challenging Time (PACT) programs within the clinic.
URL:https://lesturnerals.org/https-us02web-zoom-us-webinar-register-wn_nvixvs4-tqsr5bwy_malta-registration/march-als-learning-series-webinar-observational-studies-help-in-the-quest-for-effective-als-therapies/
END:VEVENT
END:VCALENDAR